Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism.
about
The Role of Chemokines in Promoting Colorectal Cancer Invasion/MetastasisChemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overviewCXCR3 in carcinoma progressionChemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesC-X-C ligand 10 and C-X-C receptor 3 status can predict tamoxifen treatment response in breast cancer patientsCCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinomaMolecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.Expression of CXCR-4 and IDO in human colorectal cancer: An immunohistochemical approach.The role of chemoattractant receptors in shaping the tumor microenvironment.TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis.The expression of chemokine receptors CXCR3 and CXCR4 in predicting postoperative tumour progression in stages I-II colon cancer: a retrospective study.A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection.The emerging role of CXC chemokines and their receptors in cancer.Bioinformatic analysis of patient-derived ASPS gene expressions and ASPL-TFE3 fusion transcript levels identify potential therapeutic targetsAn increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinomaCXCR3 chemokine receptor signaling mediates itch in experimental allergic contact dermatitisCell Trafficking in Chronic Lymphocytic LeukemiaAn integrated method for the identification of novel genes related to oral cancerCXCR7 receptors facilitate the progression of colon carcinoma within lung not within liverCXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity.NF-κB signaling regulates cell-autonomous regulation of CXCL10 in breast cancer 4T1 cells.Cell surface markers in colorectal cancer prognosis.Molecular mechanisms of liver metastasis.Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?Targeting tumor cell motility as a strategy against invasion and metastasis.The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition.Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome.Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells.Designing small molecule CXCR3 antagonists.The role of CXCR3 and CXCR4 in colorectal cancer metastasis.Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patients.Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration.SSeCKS/AKAP12 scaffolding functions suppress B16F10-induced peritoneal metastasis by attenuating CXCL9/10 secretion by resident fibroblasts.The expression of chemokine receptors CCR6, CXCR2 and CXCR4 is not organ-specific for distant metastasis in colorectal cancer: a comparative study.Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer.CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer.High expression of CXCR3 is an independent prognostic factor in glioblastoma patients that promotes an invasive phenotype.Critical Role of the CXCL10/C-X-C Chemokine Receptor 3 Axis in Promoting Leukocyte Recruitment and Neuronal Injury during Traumatic Optic Neuropathy Induced by Optic Nerve Crush.
P2860
Q26748194-4E844215-2708-46A6-9EDD-590D118AC333Q26774619-0704DC8D-2A6B-44F4-AFC6-0B9C1369A3EAQ26826928-3DA5255C-2DB0-4113-AB66-AE093DAFBB89Q26866236-AE0E2567-F3E7-4618-96E1-55DF02652EC0Q28383941-8CB08339-41E9-4910-ABAC-5ACD79664443Q28741084-A8BB96B7-CD73-491F-9ABA-5CF520979078Q33628125-850D59A1-12D0-4C1C-B6B0-56752B1C9E91Q33684895-AB9C525C-0341-4D64-81F9-2FDF9DC60CD3Q33993124-A1246D27-43D3-4640-84AE-D56260FDE999Q34020909-35AC6712-BDB6-4B95-AE41-AC8268E4EC82Q34071833-4C88048F-1B95-4DCE-BA15-07F3123EFF10Q34122827-81710E32-62E5-46C4-A94A-410DC77D13CCQ34263645-491C3350-C2A0-4616-9278-6AA5A8778649Q34504946-264A1FCB-5792-4A26-896B-BD45FC3C99D9Q35122843-8A2D11BB-62B0-4DA8-A649-1E2AEFF573E1Q35985416-059EB28C-D842-43ED-9262-C82642E52427Q36115034-7960679E-83D4-45CA-BF04-F65D53921349Q36338202-0D618766-74FD-4F87-8B4D-9B5FDE79009EQ36451759-E76162AE-49D9-431E-99C8-651CEF12520CQ36685419-C4A0BADB-CE03-4776-85E0-3800D35B44F3Q37680059-A4904433-F3DF-449C-AD59-BADAC5C338D6Q37845669-57B5774A-803B-4A65-82FD-092616641A55Q37918848-218C4175-E02F-4583-B30F-E7041E5BB1F5Q37983913-191B9071-A600-446E-8AF5-DC56F4186976Q38097602-F8F1A7D3-2415-49E0-953D-D34F4C7D6F98Q38264904-1E09BA00-316A-44A9-95D3-4117DC2236D6Q38867618-AC00D936-E64F-4FE1-ABEA-8EC16E355D75Q39004950-46847262-720A-4E94-933B-EA5849C2B5A4Q39051765-C15B1CD8-9594-4D42-9BBD-80018F96444FQ39332870-2BD2720E-5AB7-4736-A0A3-3EAC29EF5D1FQ39413746-8AF0B6E2-49DE-4C70-8554-AC0A03DAC5FDQ41098451-8B4880FD-DBCF-4D5E-BEBE-309753A8FBA8Q41911091-686B8959-7DDC-41FC-9022-8850D78ADD34Q42378427-D3ABA33C-D673-4AB3-A953-50FA2D60B8A5Q43936561-124A0543-4CB6-493C-B472-E1D9B5E97EEFQ44175989-DB08A79A-1550-456C-95F6-155D8388A1ABQ45931583-070FA18B-40C5-4AB9-97BD-72C0CE0ED956Q47160687-BA102798-AA00-4DA9-BEDF-64F330B61B48Q48405321-0BB4C9D0-C90D-428F-A74D-C367DD0F0B05Q51014171-1C753723-503E-47C6-AF61-C96A7DDD8E08
P2860
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism.
@en
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism.
@nl
type
label
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism.
@en
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism.
@nl
prefLabel
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism.
@en
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism.
@nl
P2093
P2860
P356
P1476
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism.
@en
P2093
A Schmid-Alliana
B F Karimdjee
D Birnbaum
H Bziouech
H Schmid-Antomarchi
J C Medina
J Y Scoazec
M A Millet
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605078
P407
P577
2009-05-12T00:00:00Z